These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Essential arginine residues in the pyridine nucleotide binding sites of glutathione reductase.
    Author: Boggaram V, Mannervik B.
    Journal: Biochim Biophys Acta; 1982 Feb 04; 701(1):119-26. PubMed ID: 7055581.
    Abstract:
    Glutathione reductase (NAD(P)H: oxidized-glutathione oxidoreductase, EC 1.6.4.2) from human erythrocytes as well as from other sources was inactivated irreversibly by the arginine modifying reagents 2,3-butanedione, 1,2-cyclohexanedione and phenylglyoxal. The inactivation caused by these reagents increased with time and was biphasic in nature. Inactivation by 2,3-butanedione in borate buffer could be partially reversed by dialysis against phosphate buffer or by incubation with hydroxylamine. The dicarbonyl reagents simultaneously inactivated the transhydrogenase activity of glutathione reductase that is expressed by the pyridine nucleotide sites. Amino acid analysis of enzyme modified with 2,3-butanedione showed a decrease by about 5 in the number of arginine residues. Analysis of enzyme inactivated with phenylglyoxal indicated modification of two arginine residues. NADPH, NADP/ and other adenosine 2'-phosphate nucleotides partially protected the enzyme against inactivation. GSSG did not protect the enzyme significantly. Modified glutathione reductase displayed a diminished affinity for the nucleotides as shown by affinity chromatography on 2',5'-ADP-Sepharose and by stopped-flow kinetics of the reduction of the enzyme. Modification did not cause any gross structural changes of enzyme molecule. It is concluded that some of the arginine residues modified are located at the pyridine-nucleotide-binding sites of the enzyme.
    [Abstract] [Full Text] [Related] [New Search]